Skip to main content
Gabriel Roman Souza, MD, Oncology, Tampa, FL

Gabriel Roman Souza MD


Physician

Join to View Full Profile
  • 17 Davis BlvdSte 308Tampa, FL 33606

Dr. Roman Souza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • H. Lee Moffitt Cancer Center and Research Institute
    H. Lee Moffitt Cancer Center and Research InstituteFellowship, Hematology and Medical Oncology, 2023 - 2026
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2020 - 2023
  • Universidade Federal de Santa Catarina
    Universidade Federal de Santa CatarinaClass of 2018, MD
  • Universidade Estadual de Ponta Grossa
    Universidade Estadual de Ponta GrossaJuris Doctor (JD), 2008 - 2012

Certifications & Licensure

  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Fellow SPOTTED award H. Lee Moffitt Cancer Center and Research Institute, 2023-2024
  • Abstract achievement award (co-author - Andrew Ta) American Society of Hematology, 2023
  • Abstract achievement award (co-author - Amna Naqvi) American Society of Hematology, 2023
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Sebaceous Carcinoma of the Eyelid in a Patient with Muir-Torre Syndrome Treated with Pembrolizumab: A Case Report  
    Abdalla A, Roman Souza G, Mahadevan D, Current Problems in Cancer: Case Reports, 4/2/2022
  • Metastatic Thymic Carcinoma with novel KIT mutations masquerading as a Carcinoma of Unknown Primary Site  
    Roman Souza G, Hackman S, Chamberlin KE, Kovalskyy D, Mumbower AL, Mahadevan D, Clinical Oncology: case reports, 7/2021

Abstracts/Posters

  • Updated efficacy, safety, and correlative analysis of a phase II trial in metastatic renal cell carcinoma with coordinated pembrolizumab and high dose IL-2.
    Jeffrey S Johnson, Mayer N Fishman, Michael J Schell, Xiaoqing Yu, Xuefeng Wang, Gabriel Roman Souza, Justin Miller, Sarah Raymond Mizelle, Keerthi Gullapalli, Adnan N..., Journal of Clinical Oncology, 2/18/2025
  • Optimizing clear cell renal cell carcinoma tumor-infiltrating lymphocytes under controlled hypoxic conditions.
    Jad Chahoud, Marine Potez, Christopher Guske, Justin Miller, Johannes Ali, Michael Carter, Fatema Khambati, Jeffrey S Johnson, Adnan Nazir Fazili, Keerthi Gullapalli, ..., Journal of Clinical Oncology, 2/18/2025
  • A phase II trial of dostarlimab and niraparib combination therapy in patients with stage III-IV recurrent or refractory penile cancer.
    Gabriel Roman Souza, Curtis Alvin Pettaway, Matthew T Campbell, Robin Neubauer, Andrew Johns, Sarah Raymond Mizelle, Youngchul Kim, Jus Chadha, Jingsong Zhang, Ghazal ..., Journal of Clinical Oncology, 2/18/2025
  • Join now to see all

Committees

  • Journal Section Editor, Current Treatment Options in Oncology 2024 - Present

Professional Memberships

Other Languages

  • Portuguese

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: